As a sine qua non for arterial wall physiology, local hemodynamic forces such as endothelial shear stress (ESS) may influence long-term vessel changes as bioabsorbable scaffolds dissolve. The aim of this study was to perform serial computational fluid dynamic (CFD) simulations to examine immediate and long-term haemodynamic and vascular changes following bioresorbable scaffold placement. 
Introduction
The fundamental concept of a stent and its complications has not changed greatly since pioneering work in the early 20th century. 1 The technology underlying these devices, however, has undergone great and rapid advances that seem, perhaps, to be accelerating.
Despite excellent clinical outcomes with current generation of metallic drug-eluting stents, their permanent nature remains a theoretical limitation. In that sense, the adoption of bioresorbable materials is one recent leap forward in stent technology. The ideal bioresorbable stent is meant to fulfil a temporary function as a vascular scaffold to aid vessel healing and stabilisation, and then disappear.
The Absorb Bioresorbable Vascular Scaffold (BVS, Abbott Vascular, Santa Clara, CA, USA) has been the most implanted and studied bioresorbable scaffold. The longest-term clinical data currently available indicates 5-year outcomes similar to standard comparator metallic drug-eluting stents. 2, 3 Resorption of the Absorb may also be accompanied by a partial and gradual return of normal vasomotion, late lumen enlargement, and plaque stabilisation. [4] [5] [6] [7] [8] However, recent evidence from larger trials shows that while rare, late thrombosis occurs more frequently with the Absorb scaffold. [9] [10] [11] There remain many unanswered questions regarding the mechanisms of late scaffold complications, but certain clues may lie in the dynamics of blood flow after scaffolding. Fluid shear stress exerted by blood flow directly regulates vascular physiology and pathology. 12, 13 Changes in arterial geometry induced by stent or scaffold placement can significantly change blood flow throughout the vessel, 14 ,15 thereby altering the macro-level shear stress distribution. Individual stent struts may themselves disturb flow at an even smaller scale near the endothelium, [16] [17] [18] [19] creating so-called micro-level disturbances. After implantation, such macro-and microlevel flow disturbances may have repercussions not only for the development of scaffold thrombosis and restenosis, but also for appropriate neointimal healing and vessel remodelling. The aim of this study was to perform serial high-fidelity computational fluid dynamic (CFD) simulations to examine immediate and long-term haemodynamic and vascular changes following bioresorbable scaffold placement.
Methods

Patient selection and study design
Patients with serial imaging from the ABSORB Cohort B clinical trial were retrospectively identified for further computational analysis. The original study design and protocol have been previously described. 20 Patients underwent serial invasive imaging with coronary angiography and optical coherence tomography (OCT) immediately after scaffold implantation and again at 5 years. Exclusion criteria were lack of two angiographic views separated by >25
, excessive vessel foreshortening, suboptimal OCT images, and side branches >2 mm within the scaffold which prohibited 3D reconstruction. Angiography and OCT images from each time point were fused to reconstruct 3D models of the scaffolded artery at baseline and 5 years. Computational fluid dynamic analysis was then performed to calculate endothelial shear stress (ESS) and local blood viscosity at baseline and 5 years.
Image acquisition and data analysis
Optical coherence tomography is an intravascular imaging technique providing high-resolution (10-20 lm) cross-sectional images of coronary arteries and scaffolds. 21 Optical coherence tomography was performed immediately after scaffold implantation and at 5 years in all treated coronary arteries using a frequency-domain OCT system (C7-XR or C8XR OCT Intravascular Imaging System; St. Jude Medical, St. Paul, MN, USA). All image acquisitions were performed using non-occlusive contrast flushing according to standard guidelines. 21 Angiography was performed as previously described. 20 Three-dimensional arterial reconstruction
For each time point, OCT and angiography were fused to reconstruct patient-specific 3D models of the scaffolded artery at baseline and 5 years ( Figure 1) . 22 Briefly, dual plane end-diastolic angiographic images (orthogonal views >25 difference) were used to extract the 3D luminal centreline (QAngio XA 3D, Medis Specials Bv, Netherlands). The radiopaque scaffold markers and side branches were used as landmarks to co-register angiography with OCT. The OCT lumen and scaffold contours were semiautomatically detected (QCU-CMS v4.69, LKEB, Leiden University, Netherlands). The contours were placed onto the angiographic centreline using scaffold markers and vessel landmarks to correct the rotational and longitudinal orientation of the OCT frames (MATLAB R2015b, Mathworks Inc., Natick, MA, USA), and the baseline and 5-year scaffolded vessel surfaces were generated (Meshlab, Visual Computing Lab ISTI-CNR, Pisa, Italy). 23 
Computational fluid dynamic simulation
Each reconstruction was discretised into approximately 30 million tetrahedral elements using ICEM CFD v15.0 (ANSYS Inc., Canonsburg, PA, USA). Computational fluid dynamic analysis was accomplished through direct solution of the incompressible Navier-Stokes equations describing fluid motion (OpenFOAM-2.1.1, OpenCFD Ltd, ESI group, Bracknell, UK). A time-varying (pulsatile) parabolic velocity profile with a mean inlet flow of 1.3 cc/s was applied at the inlet. The arterial wall was considered rigid with a no-slip boundary and a non-specific distal vascular resistance was applied at the outlet. Blood density was assumed 1060 kg/m 3 and haematocrit 45%. Non-Newtonian blood behaviour was modelled using the Quemada equation, in which viscosity varies depending on shear rate and haematocrit. 24 OpenFOAM was run on the Victorian Life Sciences
Computation Initiative (VLSCI) supercomputer consisting of 1024 IBM Blue Gene/Q CPUs at 1.6 GHz (IBM Research, Australia). Endothelial shear stress was calculated as the product of viscosity and velocity gradient (shear rate) at the wall. For quantitative calculations ESS was classified as low (<1 Pa), moderate (1-7 Pa), or high (>7 Pa) (see Supplementary material online, Methods). [25] [26] [27] Percent lumen area exposed to low, moderate, and high ESS at systolic, diastolic, and timeaveraged flow was determined at baseline and 5 years. In order to assess the change in lumen dimensions, the baseline and 5-year arterial reconstructions were matched by using the scaffold markers and anatomical landmarks. The impact of baseline ESS on the change in lumen area was investigated.
Due to its shear-thinning properties, blood exhibits higher viscosity at low shear rates and approaches a constant low viscosity at high shear rates. Computational fluid dynamic simulations using a Newtonian model of blood behaviour assume that shear rate is high enough that viscosity is constant (0.0035 Pa s). However, the non-Newtonian model used in this study allowed direct calculation of local blood viscosity, 24 which was expressed as a ratio of non-Newtonian to constant Newtonian viscosity 28, 29 and henceforth referred to as relative viscosity. Maximum relative blood viscosity was determined at systolic, diastolic, and time-averaged flow at baseline and 5 years. 
Statistical analysis
Continuous variables were reported as mean (standard deviation) if they followed a Gaussian distribution. Binary variables were reported as counts and percentages. Changes in ESS between baseline and 5 years were compared with a generalized linear mixed-effect model with a random intercept. To examine the association between baseline shear stress and changes in luminal area a one-level hierarchical linear model was used. No formal hypothesis testing was planned. A Wilcoxon rank sum test was used to evaluate the change in relative blood viscosity. All P-values were two-sided. However, the P-values presented are exploratory analyses only, and should therefore be interpreted cautiously. A nonparametric Robust method (CLSI C28-A3) was used to calculate 95% confidence interval. 30 Data analysis was performed using SPSS, version 24
(Chicago, IL, USA).
Results
Seven patients (seven lesions) fulfilled the study criteria and were included in the present analysis. The scaffold was implanted the left anterior descending coronary artery (5), left circumflex artery (1), and right coronary artery (1). Patient characteristics are demonstrated in Table 1 . Procedural characteristics are shown in Table 2 .
None of the patients developed adverse clinical events including death, myocardial infarction, revascularisation, or scaffold thrombosis during 5 years of clinical observation (see Supplementary material online, Table S1 ).
Since peak coronary flow occurs during diastole, the vessel was exposed to predominantly high ESS (Take home figure A and C) without evidence of micro-recirculation. During systole, a rapid drop in coronary flow results in exposure to very low ESS (Take home figure B and D) and, due to the steep negative flow gradient, unmasks micro-recirculation of blood between scaffold struts at baseline (Take home figure B1 and B2). By 5 years, ESS has homogenised to figure D1 and D2 ).
Quantitative measurements demonstrate that although ESS distribution varied considerably through the cardiac cycle, the mean percent lumen area exposed to ESS <1 Pa significantly decreased between baseline and 5 years during diastolic, systolic, and timeaveraged conditions (diastole: 6.90 vs. 2.78%, P = 0.008; systole: 53.31 vs. 38 .37%, P = 0.042; time-averaged: 15.92 vs. 4 .99%, P < 0.0001) ( Table 3) . Although individual cases demonstrated slightly different patterns of increases in moderate and high ESS (Figure 2 ) (see Supplementary material online, Table S2 ), overall mean vessel exposure to moderate and high ESS did not significantly change over 5 years in diastolic, systolic, or time-averaged flow conditions ( Table 3) . Figure 3 represents the relationship between post-implantation ESS and the change in lumen area over 5 years. A positive association was observed (y = 0.32x-1.49; P < 0.0001), indicating that higher baseline ESS values after scaffold implantation were correlated with an increase in lumen area. A serial point-by-point analysis was also performed to investigate the change in lumen radius, and demonstrated a similar qualitative relationship to baseline ESS (Figure 4) .
High blood viscosity was apparent in two broadly distinctive regions: at the centre of the artery where shear rate is low but blood velocity is high, and at specific locations near the lumen surface where both shear rate and blood velocity are low. Notably, near-wall regions of high blood viscosity were observed in the vicinity of 3.21 , P = 0.028) ( Table 4) . Like ESS, viscosity also fluctuated considerably throughout the cardiac cycle, peaking in systole for all cases at both baseline and 5 years (see Supplementary material online, Table S3 ). Remarkably, in Cases 1, 5, and 7 the maximum relative viscosity approached a 10-fold increase in some locations at baseline.
Discussion
The high fidelity CFD simulations conducted in this study revealed that haemodynamics in scaffolded coronary arteries are marked by wide fluctuation in ESS throughout the cardiac cycle, resulting in transient micro-recirculation, and pockets of high blood viscosity in the scaffolded region that largely disappear as the scaffold dissolves. This process was accompanied by vessel exposure to more physiological levels of ESS, reduced peak blood viscosity, and late lumen enlargement over 5 years. 12, 13 Abnormally low and high ESS have been correlated with atherosclerotic plaque progression, vulnerability, and perhaps even disruption, platelet activation, and subsequent thrombosis. [33] [34] [35] [36] Similarly, changes in arterial geometry induced by stent or scaffold placement can also significantly alter blood flow and ESS distribution at the strut and vessel scale. 37 Such post-intervention flow disturbances may have repercussions for the development of scaffold thrombosis and restenosis. 15, 18, 38 In order to gain new insights into local haemodynamics within scaffolded arteries, this study employed serial OCT imaging over 5 years as the basis for CFD analysis. Due to the use of pulsatile flow conditions and a non-Newtonian model of blood behaviour, these simulations are of unprecedented scope and detail. This methodology has allowed several key observations. 
First, higher ESS values immediately after scaffold implantation are significantly correlated with lumen enlargement by 5 years. Several intravascular ultrasound based studies in native arteries and OCTbased studies in scaffolded arteries suggest a similar relationship between ESS and subsequent vessel change. 36, [39] [40] [41] [42] Whether this phenomenon is unique to polymeric bioresorbable devices is unknown, but the consistent upward shift in ESS values observed in this study may continue to push the balance toward positive Glagovian remodelling and late lumen enlargement. 8, [43] [44] [45] Second, there is significant fluctuation in ESS and relative blood viscosity throughout the cardiac cycle, indicating that coronary arteries experience extreme absolute values and sudden shifts in local haemodynamics with each heartbeat. Exceptionally high ESS values identified in diastole are notable given the putative role of high ESS in platelet activation, plaque destabilisation, and perhaps even rupture. 33, 35, 46 Conversely, the rapid drop in coronary flow at the onset of systole unmasks micro-recirculation of blood between scaffold struts, reflecting areas prone to momentary blood stagnation and high viscosity in every cardiac cycle. In fact, after scaffold implantation blood manifested up to a 10-fold increase in relative viscosity around scaffold struts during systole. Some regions of high viscosity persisted even in diastole. Third, regardless of time point within the cardiac cycle, all cases demonstrated homogenisation of ESS over 5 years, with less exposure to atherogenic low ESS and increased exposure to moderate and high ESS which are generally thought to be more atheroprotective. Critically, this was accompanied by a significant reduction in maximum blood viscosity. Immediately after implantation, microrecirculation, low ESS, and high peak viscosity within the scaffolded region may contribute to early accumulation of fibrin, platelets, and other blood components just distal to each strut. 47 In a sense, the scaffold may act as a template for neointimal growth between struts as these aggregated materials organize. Once neointimal tissue has grown to cover the struts and the lumen surface becomes smooth, the alternans of high and low ESS dissipates, overall ESS increases, and peak viscosity is reduced. In such an ideal scenario there is no longer strong stimulus for thrombosis or neointimal hyperplasia. Remarkably, as bioresorbable devices dissolve, underlying arteries have demonstrated a partial and gradual return of normal arterial vasoreactivity and plaque stabilisation in addition to late lumen gain. [4] [5] [6] [7] We postulate that some of these observations may be related to the normalisation of haemodynamics after scaffold implantation.
Although none of the patients in the current study developed adverse clinical events during 5 years of follow-up, our findings may add to previous work in explaining certain mechanisms of scaffold thrombosis and the potential mechanisms of long-term benefit. Factors associated with very late scaffold thrombosis include poor neointimal healing, uncovered struts, and persistent scaffold malapposition. 32 In some cases, suboptimal local haemodynamics immediately after scaffold implantation may contribute to poor neointimal growth and persistently uncovered or malapposed struts. 17 Such struts protruding into the lumen are exposed to high ESS, which is associated with platelet activation. 46 Regions distal to protruding struts are prone to low ESS and high viscosity, where activated platelets can aggregate. Non-Newtonian simulations provide uniquely complementary haemodynamic data about blood viscosity. Blood is a nonNewtonian fluid with primarily shear-thinning properties: at low shear rates blood is thick, but at high shear rates it becomes thinner with viscosity approaching a constant. Although most arterial CFD simulations safely assume that blood behaves as a Newtonian fluid with a constant viscosity, under certain flow conditions the local shear rate can drop enough that the Newtonian assumption no longer holds. [48] [49] [50] [51] This appears to be the case in coronary arteries under pulsatile flow and harbouring curvatures and scaffolds: even after averaging viscosity throughout each entire simulated artery, relative blood viscosity was approximately 35% greater than the Newtonian model, a finding consistent with previous studies in unstented arteries. 29, [52] [53] [54] That we have demonstrated discrete and consistent increases in blood viscosity in patient-specific scaffolded coronary arteries suggests that the Newtonian assumption may not always be accurate in this setting. The ability to measure local blood viscosity in vivo has the potential to add an entirely new dimension to the study of local arterial haemodynamics. Although some clinical evidence points to a correlation between higher plasma viscosity and coronary disease, 55 whether and how local blood viscosity relates to clinical outcomes will require much larger dedicated studies. Additionally, previous CFD studies suggest that neglecting non-Newtonian behaviours of blood may reduce the accuracy of ESS measurements. [48] [49] [50] This may partially explain the persistent limitation of ESS to detect and predict progressive atherosclerosis. 56 It is possible that in combination with traditional wall-based haemodynamic metrics, non-Newtonian simulations and viscosity calculations may improve the accuracy and specificity of CFD simulations by identifying areas at risk for platelet 
Limitations
This study has several limitations that must be acknowledged. First is the retrospective design, which means that OCT acquisition techniques to optimise arterial reconstruction were not specified in the original protocol. Second is the low number of cases studied. This was related to the low number of patients with serial OCT in the original study, but also to the absence of pre-defined OCT acquisition standards leading to several OCT studies that were suboptimal for arterial reconstruction. Due to our strict exclusion criteria, all such cases were excluded from CFD analysis, contributing to the low number of cases. Despite a small sample size, the overall consistency of our results suggests that the observations may indeed merit further investigation through dedicated pre-specified substudies of larger clinical device trials. Third, our analysis only included interval changes in lumen dimensions-it did not explicitly evaluate tissue characteristics. Quantitative OCT tissue characterisation is currently in development, and will provide further insights into the relationship between local haemodynamics and tissue changes in the future. 57 Fourth, although differences in scaffold architecture, connector design, and strut geometry will alter the haemodynamic microenvironment, CFD principles are universal and remain operational in the analysis of other scaffold designs. 58 Using CFD, our group has investigated two other scaffold designs with different strut thicknesses, the Mirage Bioresorbable Microfiber Scaffold (125 mm) and the ArterioSorb scaffold (95 mm). In both preclinical and randomized clinical trials, we have demonstrated that the circular struts of the Mirage become better embedded such that the area of laminar flow disturbances and low ESS were reduced from 49.30% in Absorb to 24 .48% in Mirage (P < 0.0001). [59] [60] [61] In addition, using pulsatile and non-Newtonian CFD, we have shown that the ArterioSorb scaffold exhibits major reductions in area of low ESS area compared to Absorb, and in fact shear stress assessment has been reported as 'a method to differentiate bioresorbable scaffold platforms'. 58 
Conclusion
In conclusion, high fidelity pulsatile non-Newtonian CFD simulations reveal micro-and macro-level haemodynamics in scaffolded coronary arteries. Early haemodynamic disturbances induced after scaffold implantation may direct subsequent neointimal growth as the scaffold degrades, leading to more physiological ESS, reduced peak blood viscosity, and in some cases lumen enlargement. The ability to identify intravascular regions of high blood viscosity may have implications for further clinical characterisation of thrombosis, neointimal growth, and vessel healing.
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